Argent BioPharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	1.53	1.02	0.7	0.24	1.89	5.43
Cash & Short-Term Investments	1.53	1.02	0.7	0.24	1.89	5.43
Cash Growth	112.90%	45.75%	193.08%	-87.29%	-65.28%	190.03%
Accounts Receivable	0.24	0.07	0.14	0.21	0.74	0.84
Other Receivables	-	0.31	0.34	0.32	1.2	1.51
Receivables	0.24	0.38	0.48	0.53	1.94	2.35
Inventory	-	0.13	0.88	1.36	1.84	0.87
Prepaid Expenses	0.12	0.5	0.69	0.4	0.8	0.55
Other Current Assets	-	-	-	-	-	0.28
Total Current Assets	1.89	2.03	2.74	2.53	6.46	9.48
Property, Plant & Equipment	0.12	0.44	6.72	7.45	8.8	7.14
Long-Term Investments	-	-	1.33	-	0.16	0.56
Goodwill	-	-	-	-	3.15	7.05
Total Assets	2.01	2.47	10.79	9.98	18.56	24.24
Accounts Payable	1.54	1.81	0.96	2.19	2.52	1.22
Accrued Expenses	-	0.32	0.35	0.54	0.69	0.38
Short-Term Debt	7.53	7.93	8.68	9.18	2.1	4.03
Current Portion of Leases	0.01	0.11	0.22	0.19	0.28	0.21
Current Unearned Revenue	-	-	0.55	0.66	1.81	-
Other Current Liabilities	-	0.66	1.42	0.58	0.31	0.28
Total Current Liabilities	9.09	10.83	12.18	13.33	7.71	6.13
Long-Term Leases	0.06	0.25	0.82	0.38	1.97	1.77
Long-Term Unearned Revenue	-	-	3.6	4.28	3.68	2.51
Other Long-Term Liabilities	1.31	0.02	0.02	0.02	0.02	-
Total Liabilities	10.46	11.1	16.61	18.02	13.38	10.41
Common Stock	139.62	138.59	123.29	103.69	97.25	84.51
Retained Earnings	-150.45	-147.51	-129.67	-119.17	-98.35	-78
Comprehensive Income & Other	2.38	0.3	1.23	8.08	6.93	7.32
Total Common Equity	-8.44	-8.63	-5.15	-7.4	5.84	13.83
Minority Interest	-	-	-0.67	-0.63	-0.66	-0.01
Shareholders' Equity	-8.44	-8.63	-5.82	-8.03	5.18	13.83
Total Liabilities & Equity	2.01	2.47	10.79	9.98	18.56	24.24
Total Debt	7.6	8.29	9.72	9.75	4.35	6.02
Net Cash (Debt)	-6.07	-7.26	-9.02	-9.51	-2.47	-0.58
Net Cash Per Share	-0.09	-0.13	-0.24	-3.23	-0.96	-0.31
Filing Date Shares Outstanding	83.38	72.18	48.41	4.43	2.85	2.39
Total Common Shares Outstanding	83.38	72.18	45.28	3.35	2.73	2.32
Working Capital	-7.2	-8.8	-9.44	-10.8	-1.25	3.35
Book Value Per Share	-0.10	-0.12	-0.11	-2.21	2.14	5.96
Tangible Book Value	-8.44	-8.63	-5.15	-7.4	2.69	6.79
Tangible Book Value Per Share	-0.10	-0.12	-0.11	-2.21	0.99	2.93
Machinery	0.14	0.95	9.79	10.04	9.07	1.94
Construction In Progress	-	-	-	-	-	4.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.